Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
98.42B | 92.33B | 94.51B | 76.09B | 62.85B | 71.80B | Gross Profit |
21.37B | 17.92B | 19.21B | 17.98B | 14.96B | 17.96B | EBIT |
1.93B | -211.00M | 1.71B | 3.25B | 1.58B | 3.75B | EBITDA |
4.55B | 3.06B | 5.22B | 5.44B | 4.93B | 6.06B | Net Income Common Stockholders |
-328.00M | -1.16B | 885.73M | 1.75B | 1.09B | 2.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.55B | 6.85B | 6.30B | 6.63B | 3.48B | 4.01B | Total Assets |
99.86B | 98.58B | 92.44B | 78.91B | 69.39B | 71.40B | Total Debt |
41.25B | 39.37B | 33.67B | 21.50B | 17.68B | 17.91B | Net Debt |
37.70B | 32.74B | 27.37B | 16.14B | 14.20B | 13.90B | Total Liabilities |
62.72B | 57.70B | 51.62B | 38.80B | 31.95B | 33.65B | Stockholders Equity |
36.50B | 37.22B | 37.10B | 36.74B | 34.57B | 35.13B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.08B | -4.80B | -22.99M | 712.74M | 2.52B | Operating Cash Flow |
0.00 | 353.00M | -466.24M | 2.83B | 3.01B | 6.19B | Investing Cash Flow |
0.00 | -3.20B | -6.65B | -3.44B | -1.86B | -3.46B | Financing Cash Flow |
0.00 | 2.90B | 7.66B | 2.11B | -1.56B | -2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥17.70B | 11.97 | 3.56% | 4.85% | 80.14% | ||
72 Outperform | ¥15.40B | 9.84 | 2.77% | 5.96% | 182.60% | ||
72 Outperform | ¥17.96B | 11.71 | 3.93% | 10.43% | 187.34% | ||
71 Outperform | ¥20.89B | 7.90 | 4.75% | 11.10% | ― | ||
69 Neutral | ¥17.52B | 6.85 | 4.62% | 0.79% | 61.23% | ||
59 Neutral | ¥19.78B | 24.99 | 5.34% | 9.40% | ― | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |
Harima Chemicals Group, Inc. announced a dividend distribution from surplus, maintaining a dividend per share of 21 yen for FY2024, consistent with the previous fiscal year. This decision reflects the company’s stable financial performance and commitment to returning value to shareholders, indicating a positive outlook for stakeholders.
Harima Chemicals Group, Inc. announced significant senior personnel changes, which were decided at the Board of Directors’ Meeting and will be finalized at the upcoming Shareholders’ Meeting. These changes include reassignments and new appointments in several key positions, reflecting the company’s strategic direction and potentially impacting its operational focus and market positioning.
Harima Chemicals Group, Inc. reported a significant discrepancy between its forecasted and actual consolidated results for fiscal 2024, with decreases in net sales, operating income, ordinary income, and net income attributable to the company. The decline was attributed to lower sales in the Lawter business due to reduced selling prices, increased raw material costs in the Electronic Materials sector, and higher overseas interest expenses. Additionally, an extraordinary loss was recorded due to an impairment of assets in its New Zealand subsidiary, impacting the company’s financial performance.
Harima Chemicals Group, Inc. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 9.4% to 101,006 million yen. The company also returned to profitability, posting a net income of 763 million yen compared to a loss in the previous year. This positive turnaround is attributed to strategic operational adjustments and market conditions, positioning the company favorably for future growth.